Clinical Equivalency [qlco]
Intranasal [spco]
Oral [spco]
17 beta-Estradiol [horm, phsu, strd]
postmenopausal symptoms [dsyn]
Objective [inpr]
Study [mnob]
Clinical Equivalency [qlco]
Novel [tmco]
Intranasal [spco]
Estradiol [horm, phsu, strd]
Formulation [resa]
Reference [idcn]
Oral [spco]
Drug [phsu]
Study Design [resa]
Double-Blind Study [resa]
Parallel [qlco]
Group [idcn]
postmenopausal [tmco]
Women [popg]
Moderate [qlco]
severe symptoms [fndg]
postmenopausal [tmco]
Assigned [ftcn]
Receive [qlco]
Mu [inpr]
g d [qnco]
Intranasal [spco]
17 beta-Estradiol [horm, phsu, strd]
2-D [spco]
mg% [qnco]
Oral [spco]
micronized estradiol [orch, phsu]
Plus [qlco]
Appropriate [qlco]
placebo [topp]
weeks [tmco]
Patients [podg]
Received [qlco]
mg/d [qnco]
Dydrogesterone [horm, phsu, strd]
days [tmco]
Cycle [tmco]
Adjustment [inbe]
Intranasal [spco]
Dosage [qnco]
permitted [fish]
Primary [qlco]
Efficacy [qlco]
Criterion [inpr]
Index [inpr]
limit [ftcn]
Equivalent [qlco]
Index [inpr]
Scores [qnco]
Improved [qlco]
Group [idcn]
SD [fndg]
Oral [spco]
therapy [ftcn]
Group [idcn]
>90 [qnco]
Equivalent [qlco]
limit [ftcn]
Statistical [ocdi]
P NOS [aapp, imft]
Daily [tmco]
Intensity [qlco]
Hot flushes [sosy]
Decreased [qnco]
treatment [ftcn]
Group [idcn]
Withdrawal bleeding [dsyn]
Intranasal [spco]
therapy [ftcn]
>90 [qnco]
Severe [qlco]
Mastalgia [sosy]
Group [idcn]
Group [idcn]
Oral [spco]
therapy [ftcn]
P NOS [aapp, imft]
Triglyceride [bacs, lipd]
Angiotensinogen [aapp, bacs]
Levels [qlco]
Increased [qnco]
Oral [spco]
therapy [ftcn]
Same [qlco]
Patients [podg]
Required [ftcn]
Dose [qnco]
adaptation [orgf]
Group [idcn]
Approximately [qlco]
Administration, Intranasal [topp]
Mu [inpr]
g d [qnco]
Estradiol [horm, phsu, strd]
effective [qlco]
Administration, Oral [topp]
2-D [spco]
mg% [qnco]
Estradiol [horm, phsu, strd]
postmenopausal symptoms [dsyn]
Mastalgia [sosy]
Uterine Bleeding [patf]
Metabolic [ftcn]
consequences [ftcn]
First pass [tmco]
